These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21416609)

  • 21. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case study and application of process analytical technology (PAT) towards bioprocessing: II. Use of ultra-performance liquid chromatography (UPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Wood R; Sharma A; Dermawan S
    Biotechnol Bioeng; 2008 Dec; 101(6):1366-74. PubMed ID: 18814284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperosmolarity enhances transient recombinant protein yield in Chinese hamster ovary cells.
    Zhang X; Garcia IF; Baldi L; Hacker DL; Wurm FM
    Biotechnol Lett; 2010 Nov; 32(11):1587-92. PubMed ID: 20574835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHO gene expression profiling in biopharmaceutical process analysis and design.
    Schaub J; Clemens C; Schorn P; Hildebrandt T; Rust W; Mennerich D; Kaufmann H; Schulz TW
    Biotechnol Bioeng; 2010 Feb; 105(2):431-8. PubMed ID: 19777598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 26. Scale-up analysis for a CHO cell culture process in large-scale bioreactors.
    Xing Z; Kenty BM; Li ZJ; Lee SS
    Biotechnol Bioeng; 2009 Jul; 103(4):733-46. PubMed ID: 19280669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of culture temperature on TNFR-Fc productivity in recombinant glutamine synthetase-chinese hamster ovary cells.
    Fan L; Zhao L; Ye Z; Sun Y; Kou T; Zhou Y; Tan WS
    Biotechnol Lett; 2010 Sep; 32(9):1239-44. PubMed ID: 20533076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Industry perspectives on the development of biologics.
    Kramer BC
    PM R; 2011 Jun; 3(6 Suppl 1):S132-5. PubMed ID: 21703570
    [No Abstract]   [Full Text] [Related]  

  • 29. Experiences of virus, retrovirus and retrovirus-like particles in Chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics.
    Adamson SR
    Dev Biol Stand; 1998; 93():89-96. PubMed ID: 9737383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications.
    Read EK; Park JT; Shah RB; Riley BS; Brorson KA; Rathore AS
    Biotechnol Bioeng; 2010 Feb; 105(2):276-84. PubMed ID: 19731252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Drosophila model to identify polyamine-drug conjugates that target the polyamine transporter in an intact epithelium.
    Tsen C; Iltis M; Kaur N; Bayer C; Delcros JG; von Kalm L; Phanstiel O
    J Med Chem; 2008 Jan; 51(2):324-30. PubMed ID: 18163550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous processing for production of biopharmaceuticals.
    Rathore AS; Agarwal H; Sharma AK; Pathak M; Muthukumar S
    Prep Biochem Biotechnol; 2015; 45(8):836-49. PubMed ID: 25674930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of disposable reactors to generate inoculum cultures for E. coli production fermentations.
    Mahajan E; Matthews T; Hamilton R; Laird MW
    Biotechnol Prog; 2010; 26(4):1200-3. PubMed ID: 20730774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial overview: pharmaceutical biotechnology: engineering cells for high quality biopharmaceuticals production.
    Junker BH; Young JD
    Curr Opin Biotechnol; 2014 Dec; 30():viii-x. PubMed ID: 25459164
    [No Abstract]   [Full Text] [Related]  

  • 36. Overproduction of recombinant human VEGF (vascular endothelial growth factor) in Chinese hamster ovary cells.
    Lee SB; Park JS; Lee S; Park J; Yu S; Kim H; Kim D; Byun TH; Baek K; Ahn YJ; Yoon J
    J Microbiol Biotechnol; 2008 Jan; 18(1):183-7. PubMed ID: 18239438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-process testing and limits.
    Sjöholm I
    Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
    [No Abstract]   [Full Text] [Related]  

  • 38. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid characterization and quality control of complex cell culture media solutions using raman spectroscopy and chemometrics.
    Li B; Ryan PW; Ray BH; Leister KJ; Sirimuthu NM; Ryder AG
    Biotechnol Bioeng; 2010 Oct; 107(2):290-301. PubMed ID: 20506397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery.
    Mondal MS; Gabriels J; McGinnis C; Magnifico M; Marsilje TH; Urban L; Collis A; Bojanic D; Biller SA; Frieauff W; Martus HJ; Suter W; Bentley P
    Toxicol Sci; 2010 Nov; 118(1):71-85. PubMed ID: 20631060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.